Djoko Basoeki - Central Proteina Independent Commissioner
| CPRO Stock | IDR 50.00 0.00 0.00% |
Executive
Mr. Djoko Muhammad Basoeki serves as an Independent Commissioner of PT Central Proteina Prima Tbk, formerly PT Central Proteinaprima Tbk, since June 1, 2012. He joined the Company in 1972. In 1965, he graduated with Bachelor degree in Animal Husbandry from Universitas Brawijaya and in 1975 he graduated from Institut Pertanian Bogor . Both universities are based in Indonesia. He held the position of Manager of PT Mega Mendung Mixed Farm. He was Supervisor of PT Charoen Pokphand Indonesia and held various positions at Charoen Pokphand Group, including Director. since 2012.
| Age | 73 |
| Tenure | 12 years |
| Phone | 62 21 5019 1788 |
| Web | https://www.cpp.co.id |
Central Proteina Management Efficiency
The company has return on total asset (ROA) of 0.0811 % which means that it generated a profit of $0.0811 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.127 %, meaning that it generated $0.127 on every $100 dollars invested by stockholders. Central Proteina's management efficiency ratios could be used to measure how well Central Proteina manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 8 records | EXECUTIVE Age | ||
| Meiliana | Bank Negara Indonesia | 46 | |
| Ahmad Assegaf | Bank Negara Indonesia | 51 | |
| Sigit Widyawan | Bank Negara Indonesia | 53 | |
| Pataniari Siahaan | Bank Negara Indonesia | 73 | |
| Joni Swastanto | Bank Negara Indonesia | 63 | |
| Lanny Liga | Jakarta Int Hotels | 59 | |
| Ratih Nurdiati | Bank Negara Indonesia | 57 | |
| Revrisond Baswir | Bank Negara Indonesia | 61 | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0811 |
Central Proteina Prima Leadership Team
Elected by the shareholders, the Central Proteina's board of directors comprises two types of representatives: Central Proteina inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Central. The board's role is to monitor Central Proteina's management team and ensure that shareholders' interests are well served. Central Proteina's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Central Proteina's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tobias Damek, Commissioner | ||
| Arianto Yohan, Independent Director | ||
| Hendri Laiman, Pres Director | ||
| Djoko Basoeki, Independent Commissioner | ||
| Armand Ardika, Corporate Secretary | ||
| Franciscus Affandy, Vice President Commissioner | ||
| Toto Winanto, Independent Commissioner | ||
| Aris Wijayanto, Director of Human Capital and General Affairs | ||
| Christopher Nacson, Commissioner | ||
| Saleh Yu, Vice President Director | ||
| Ilphin Wunardi, Head Division | ||
| Irwan Tirtariyadi, President Director | ||
| Fachrul Razi, President Commissioner, Independent Commissioner | ||
| Fredy Sumendap, Director |
Central Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Central Proteina a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0811 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 5.48 T | |||
| Shares Outstanding | 40.47 B | |||
| Shares Owned By Insiders | 48.75 % | |||
| Price To Book | 1.02 X | |||
| Price To Sales | 0.39 X | |||
| Revenue | 8.03 T |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Central Stock
Central Proteina financial ratios help investors to determine whether Central Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Central with respect to the benefits of owning Central Proteina security.